Ergoteles’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Ergoteles’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-39,643	Closed	-$2.38M	–	1798
2021 Q1	$2.38M	Buy	+39,643	New	+$1.44M	0.07%	258

Ergoteles's PAND Position: Q2 2021 in Review

Ergoteles sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 39,643 shares — an estimated $2.38M sold.

Ergoteles first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $2.38M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Ergoteles reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ergoteles sold 39,643 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $2.38M.
Ergoteles first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Ergoteles's Pandion Therapeutics Inc. Common Stock position peaked at $2.38M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.